Efficacy and safety of glibenclamide therapy after intracerebral haemorrhage (GATE-ICH): A multicentre, prospective, randomised, controlled, open-label, blinded-endpoint, phase 2 clinical trial
-
Published:2022-11
Issue:
Volume:53
Page:101666
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Zhao Jingjing, Song Changgeng, Li Deshuai, Yang Xiai, Yu Liping, Wang Kangjun, Wu Jun, Wang Xiaofeng, Li Dongsong, Zhang Bo, Li Binyong, Guo Jun, Feng Weikui, Fu Feng, Gu Xinrong, Qian Jian, Li Jialong, Yuan Xiangjun, Liu Qiuwu, Chen Jiang, Wang Xiaocheng, Liu Yi, Wei Dong, Wang Ling, Shang Lei, Yang Fang, Jiang WenORCID
Reference36 articles.
1. Intracerebral haemorrhage;Qureshi;Lancet,2009 2. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis;van Asch;Lancet Neurol,2010 3. The epidemiology of intracerebral hemorrhage in the United States from 1979 to 2008;Rincon;Neurocrit Care,2013 4. An update on neurocritical care for intracerebral hemorrhage;Reyes;Expert Rev Neurother,2019 5. Perihematomal edema after spontaneous intracerebral hemorrhage;Ironside;Stroke,2019
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|